Advertisement World-Class Clinical Infrastructure, Research and Innovation - Pharmaceutical Business review

Advertisement

Pharmaceutical Business review is using cookies

ContinueLearn More
Close

World-Class Clinical Infrastructure, Research and Innovation

MIDAS, Manchester’s Inward Investment Agency

The University of Manchester, Europe’s largest single-site university, is 50% focused on life sciences and is ranked first in the UK for many subjects including preclinical and human biosciences, dentistry, oncology and nursing.

The University Hospital of South Manchester is home to major breast cancer and respiratory research and treatment centres.

University staff have amassed 25 Nobel Prizes, and there are four current prize winners amongst its staff.

Fully integrated with Manchester’s clinical campus through the Manchester Academic Health Science Centre (MAHSC), the University offers an established and successful translational hub that continues to drive innovation in pharmaceuticals, medical devices and therapies.

Over 22,000 people employed in the bio and life sciences sector with 6,000+ new biomedical graduates every year.

Quick Contact World-Class Clinical Infrastructure, Research and Innovation